Related Experiment Video
Updated: Aug 25, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Susceptibility of Treponema pallidum to host-derived antimicrobial peptides
David L Cox1, Yongcheng Sun, Hsi Liu
1Sexually Transmitted Infections Branch, Division of AIDS, STD and TB Laboratory Research, Center for HIV and STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. dlc6@cdc.gov
Abstract:
LL-37 displays potent broad-spectrum activity against a number of pathogenic bacteria and is the only cathelicidin thus far identified in humans. In this study, we examined the capacity of human LL-37 and the similar CAP-18-derived peptide from rabbits to exert antimicrobial activity against the causative agent of syphilis, Treponema pallidum. We found that both peptides, as well as a truncated version of human LL-37 that contains its bactericidal domain, could exert rapid, but salt-sensitive antimicrobial activity against T. pallidum. Infectivity of T. pallidum in a rabbit model could effectively be blocked with the synthetic truncated LL-37-derived peptide WS22-N-amide.
Insights
Human cathelicidin LL-37 and a related rabbit peptide show antimicrobial activity against Treponema pallidum, the syphilis agent. A truncated LL-37 peptide blocked T. pallidum infectivity in rabbits.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- LL-37 is a human cathelicidin with broad-spectrum antimicrobial properties.
- Antimicrobial peptides are crucial in innate immunity against pathogens.
- The causative agent of syphilis, Treponema pallidum, remains a significant health concern.
Purpose of the Study:
- To investigate the antimicrobial activity of human LL-37 and a rabbit CAP-18-derived peptide against Treponema pallidum.
- To evaluate the efficacy of a truncated LL-37 peptide in blocking T. pallidum infectivity.
Main Methods:
- Testing the antimicrobial activity of LL-37 and CAP-18 peptides against T. pallidum in vitro.
- Assessing the salt sensitivity of the antimicrobial effect.
- Utilizing a rabbit model to evaluate the in vivo infectivity blocking capacity of a truncated LL-37 peptide (WS22-N-amide).
Main Results:
- Both human LL-37 and the rabbit CAP-18 peptide demonstrated rapid antimicrobial activity against T. pallidum.
- The antimicrobial activity was found to be salt-sensitive.
- The synthetic truncated LL-37 peptide WS22-N-amide effectively blocked T. pallidum infectivity in a rabbit model.
Conclusions:
- Human and rabbit cathelicidin-derived peptides exhibit potent antimicrobial effects against Treponema pallidum.
- A truncated LL-37 peptide shows therapeutic potential for blocking syphilis infection.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Inhibitors of Gram-positive Cell Wall Synthesis
Determinants of Bacterial Pathogenicity and Virulence
Antiprotozoal Agents
Clinical Significance of Antibiotic Resistance

